European Commission Approves Sanofi’s VaxRabeo – Next‑Generation Rabies Vaccine for Pre‑ and Post‑Exposure Prophylaxis Across All Age Groups
Sanofi (NASDAQ: SNY) announced that the European Commission (EC) has approved VaxRabeo (rabies virus inactivated strain Wistar) for pre‑exposure prophylaxis (PrEP) and post‑exposure prophylaxis (PEP) against rabies for all age…
Empowering Chinese Pharma’s Global Expansion
Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
